Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 63

1.

The role of chemotherapy and radiotherapy in localized extraskeletal osteosarcoma.

Heng M, Gupta A, Chung PW, Healey JH, Vaynrub M, Rose PS, Houdek MT, Lin PP, Bishop AJ, Hornicek FJ, Chen YL, Lozano-Calderon S, Holt GE, Han I, Biau D, Niu X, Bernthal NM, Ferguson PC, Wunder JS; Japanese Musculoskeletal Oncology Group (JMOG); Soft Tissue Osteosarcoma International Collaborative (STOIC).

Eur J Cancer. 2020 Jan;125:130-141. doi: 10.1016/j.ejca.2019.07.029. Epub 2019 Dec 2.

PMID:
31806415
2.

Reconstruction Using Frozen Autograft for Disseminated Phosphaturic Mesenchymal Tumor of the Humerus after a Pathological Fracture.

Kobayashi H, Hirai T, Makise N, Ushiku T, Ito N, Koga M, Ikegami M, Shinoda Y, Akiyama T, Tanaka S.

Case Rep Orthop. 2019 Sep 4;2019:3015675. doi: 10.1155/2019/3015675. eCollection 2019.

3.

Minimal clinically important differences in Toronto Extremity Salvage Score for patients with lower extremity sarcoma.

Ogura K, Uehara K, Akiyama T, Shinoda Y, Iwata S, Tsukushi S, Kobayashi E, Hirose T, Yonemoto T, Endo M, Tanzawa Y, Nakatani F, Kawano H, Tanaka S, Kawai A.

J Orthop Sci. 2020 Mar;25(2):315-318. doi: 10.1016/j.jos.2019.03.022. Epub 2019 Apr 16.

PMID:
31000377
4.

Predictive factors for complications after surgical treatment for schwannomas of the extremities.

Hirai T, Kobayashi H, Akiyama T, Okuma T, Oka H, Shinoda Y, Ikegami M, Tsuda Y, Fukushima T, Ohki T, Ishibashi Y, Sawada R, Goto T, Tanaka S.

BMC Musculoskelet Disord. 2019 Apr 11;20(1):166. doi: 10.1186/s12891-019-2538-8.

5.

Effects of surface and twinning energies on twining-superlattice formation in group III-V semiconductor nanowires: a first-principles study.

Akiyama T, Nakamura K, Ito T.

Nanotechnology. 2019 Jun 7;30(23):234002. doi: 10.1088/1361-6528/ab06d0. Epub 2019 Feb 13.

PMID:
30759424
6.

Body composition as a predictor of toxicity after treatment with eribulin for advanced soft tissue sarcoma.

Kobayashi H, Okuma T, Oka H, Okajima K, Ishibashi Y, Zhang L, Hirai T, Ohki T, Tsuda Y, Ikegami M, Sawada R, Shinoda Y, Akiyama T, Kawano H, Goto T, Tanaka S.

Int J Clin Oncol. 2019 Apr;24(4):437-444. doi: 10.1007/s10147-018-1370-8. Epub 2018 Nov 21.

PMID:
30465138
7.

Development of a patient-oriented disease specific outcome measure of health-related quality of life (HRQOL) for musculoskeletal oncology patients.

Ogura K, Uehara K, Akiyama T, Shinoda Y, Iwata S, Tsukushi S, Kobayashi E, Hirose T, Yonemoto T, Endo M, Tanzawa Y, Nakatani F, Kawano H, Tanaka S, Kawai A.

J Orthop Sci. 2019 May;24(3):539-547. doi: 10.1016/j.jos.2018.10.020. Epub 2018 Nov 13.

PMID:
30446332
8.

ASO Author Reflections: The Infiltrative Features of Chordoma.

Akiyama T.

Ann Surg Oncol. 2018 Dec;25(Suppl 3):932-933. doi: 10.1245/s10434-018-6964-x. Epub 2018 Oct 29. No abstract available.

PMID:
30374931
9.

Descriptive epidemiology and outcomes of bone sarcomas in adolescent and young adult patients in Japan.

Fukushima T, Ogura K, Akiyama T, Takeshita K, Kawai A.

BMC Musculoskelet Disord. 2018 Aug 18;19(1):297. doi: 10.1186/s12891-018-2217-1.

10.

Obturator internus muscle abscess caused by methicillin-resistant Staphylococcus aureus in an adult: A case report.

Maeda A, Saku I, Kanda S, Saita K, Akiyama T.

Int J Surg Case Rep. 2018;44:1-3. doi: 10.1016/j.ijscr.2018.01.012. Epub 2018 Feb 9.

11.

Analysis of the Infiltrative Features of Chordoma: The Relationship Between Micro-Skip Metastasis and Postoperative Outcomes.

Akiyama T, Ogura K, Gokita T, Tsukushi S, Iwata S, Nakamura T, Matsumine A, Yonemoto T, Nishida Y, Saita K, Kawai A, Matsumoto S, Yamaguchi T.

Ann Surg Oncol. 2018 Apr;25(4):912-919. doi: 10.1245/s10434-017-6268-6. Epub 2017 Nov 27.

PMID:
29181683
12.

Neutrophil-to-lymphocyte ratio after pazopanib treatment predicts response in patients with advanced soft-tissue sarcoma.

Kobayashi H, Okuma T, Oka H, Hirai T, Ohki T, Ikegami M, Sawada R, Shinoda Y, Akiyama T, Sato K, Abe S, Kawano H, Goto T, Tanaka S.

Int J Clin Oncol. 2018 Apr;23(2):368-374. doi: 10.1007/s10147-017-1199-6. Epub 2017 Oct 31.

PMID:
29086877
13.

Prevalence and clinical outcomes of hip fractures and subchondral insufficiency fractures of the femoral head in patients with tumour-induced osteomalacia.

Kobayashi H, Ito N, Akiyama T, Okuma T, Kinoshita Y, Ikegami M, Shinoda Y, Fukumoto S, Tanaka S, Kawano H.

Int Orthop. 2017 Dec;41(12):2597-2603. doi: 10.1007/s00264-017-3610-3. Epub 2017 Aug 23.

PMID:
28836028
14.

Wound management with negative pressure wound therapy in postoperative infection after open reconstruction of chronic Achilles tendon rupture.

Saku I, Kanda S, Saito T, Fukushima T, Akiyama T.

Int J Surg Case Rep. 2017;37:106-108. doi: 10.1016/j.ijscr.2017.06.027. Epub 2017 Jun 17.

15.

Reliability and Validity of the Musculoskeletal Tumor Society Scoring System for the Upper Extremity in Japanese Patients.

Uehara K, Ogura K, Akiyama T, Shinoda Y, Iwata S, Kobayashi E, Tanzawa Y, Yonemoto T, Kawano H, Kawai A.

Clin Orthop Relat Res. 2017 Sep;475(9):2253-2259. doi: 10.1007/s11999-017-5390-x. Epub 2017 May 30.

16.

The longitudinal split technique for narrow canal tibia in a case of distal femur replacement for osteosarcoma.

Akiyama T, Kanda S, Saita K.

Int J Surg Case Rep. 2017;31:266-272. doi: 10.1016/j.ijscr.2017.01.063. Epub 2017 Jan 31.

17.

Three-dimensional fluoroscopic navigation-assisted surgery for tumors in patients with tumor-induced osteomalacia in the bones.

Kobayashi H, Akiyama T, Okuma T, Shinoda Y, Oka H, Ito N, Fukumoto S, Tanaka S, Kawano H.

Comput Assist Surg (Abingdon). 2017 Dec;22(1):14-19. doi: 10.1080/24699322.2017.1282044.

PMID:
28081649
18.

Melorheostosis with recurrent soft-tissue components: a histologically confirmed case.

Hasegawa S, Kanda S, Imada H, Yamaguchi T, Akiyama T.

Skeletal Radiol. 2017 Mar;46(3):399-404. doi: 10.1007/s00256-016-2562-9. Epub 2017 Jan 6.

PMID:
28062900
19.
20.

Cross-cultural adaptation and validation of the Japanese version of the Toronto Extremity Salvage Score (TESS) for patients with malignant musculoskeletal tumors in the upper extremities.

Akiyama T, Uehara K, Ogura K, Shinoda Y, Iwata S, Saita K, Tanzawa Y, Nakatani F, Yonemoto T, Kawano H, Davis AM, Kawai A.

J Orthop Sci. 2017 Jan;22(1):127-132. doi: 10.1016/j.jos.2016.09.012. Epub 2016 Oct 12.

PMID:
27743633

Supplemental Content

Loading ...
Support Center